Syra Health Overview
Valuation check: SYRA's P/E ratio is 104.44, above the sector sector average of 35.43.
Get informed when a big investor buys or sells
+ Follow104.44
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for SYRA is 104.44. That is above the sector sector average of 35.43. Investors often review this figure alongside Syra Health's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, SYRA currently prints 104.44 for P/E ratio, while the sector average sits near 35.43. That is roughly 194.7% above the sector mean. Large gaps often invite a closer look at Syra Health's growth, margins, and balance sheet.
A P/E ratio of 104.44 for Syra Health is not 'good' or 'bad' on its own. Compare it with the peer average (35.43) and with SYRA's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting SYRA's P/E ratio (104.44), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
